Steven Cohen’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-97,300
Closed -$7.54M – 4630
2026
Q2
$6.68M Buy
97,300
+21,505
+28% +$1.22M 0.01% 1564
2026
Q1
$4.87M Buy
+75,795
New +$6.91M 0.01% 1723
2025
Q3
– Sell
-52,549
Closed -$4.85M – 2730
2025
Q2
$4.85M Sell
52,549
-234,422
-82% -$18.4M 0.01% 982
2025
Q1
$25.4M Buy
286,971
+223,883
+355% +$19.4M 0.06% 383
2024
Q4
$4.85M Sell
63,088
-230,583
-79% -$16.1M 0.01% 957
2024
Q3
$12.5M Buy
293,671
+136,926
+87% +$4.62M 0.03% 570
2024
Q2
$4.1M Buy
156,745
+108,864
+227% +$2.06M 0.01% 897
2024
Q1
$437K Buy
+47,881
New +$287K ﹤0.01% 1684

Other funds holding WGS

Steven Cohen's WGS Position: Q3 2026 in Review

Steven Cohen sold out of GeneDx Holdings (WGS) in Q3 2026, closing a stake of 97,300 shares — an estimated $7.54M sold.

Steven Cohen first reported a position in WGS in Q1 2024 and held it in 8 quarters. The position peaked at $25.4M in Q1 2025. 217 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

  • Steven Cohen reported no remaining GeneDx Holdings position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 97,300 GeneDx Holdings shares in Q3 2026, an estimated $7.54M.
  • Steven Cohen first reported a position in GeneDx Holdings in Q1 2024 and held it in 8 quarters.
  • Steven Cohen's GeneDx Holdings position peaked at $25.4M in Q1 2025.
  • 217 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.